Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Farley

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Innovations in Pharmacy|May 23, 2022
Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for ImprovementFederico Facciolo, Joel Farley
Journal of Managed Care & Specialty Pharmacy|November 26, 2025
Requiring continuous enrollment during follow-up? A call for robust research methodsSujith Ramachandran, Joel Farley, John P Bentley
Journal of Anxiety Disorders|February 23, 2013
National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from medical expenditure panel survey 2004-2009Chung-Hsuen Wu, Chi-Chuan Wang, Aaron Jacob Katz, et al.
Journal of Psychosocial Oncology|January 18, 2021
The association of continuity of care and risk of mortality in breast cancer patients with cardiometabolic comorbiditiesNing Cheng, Joel Farley, Jingjing Qian, et al.
Exploratory Research in Clinical and Social Pharmacy|August 12, 2022
Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA)Karen B Farris, Tiffany Cadwallader, Joel Farley, et al.
Journal of Managed Care & Specialty Pharmacy|February 27, 2026
Trends in 1-year persistence and adherence among initiators of high-potency, weight loss-indicated glucagon-like peptide 1 receptor agonistsLandon Z Marshall, Patrick P Gleason, Nicholas Friedlander, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 30, 2024
Managing medications for patients with cancer and chronic conditions: It's time for collaboration between primary care and oncology pharmacistsArielle Davidson, Mohamad Ismail, Justin Gatwood, et al.
The Journal of Rheumatology|August 3, 2014
Tumor necrosis factor-α inhibitor treatment and the risk of incident cardiovascular events in patients with early rheumatoid arthritis: a nested case-control studyRishi J Desai, Jaya K Rao, Richard A Hansen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 28, 2023
Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditionsJustin Gatwood, Ankur Dashputre, Abhijeet Rajpurohit, et al.
JCO Oncology Practice|June 14, 2022
Medication Adherence Among Adults With Comorbid Chronic Conditions Initiating Oral Anticancer Agent Therapy for Multiple MyelomaJustin Gatwood, Ankur Dashputre, Abhijeet Rajpurohit, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Innovations in Pharmacy|May 23, 2022
Minnesota Policy on Pharmacist-Prescribed Contraceptives: Benefits, Limitations, and Opportunities for ImprovementFederico Facciolo, Joel Farley
Journal of Managed Care & Specialty Pharmacy|November 26, 2025
Requiring continuous enrollment during follow-up? A call for robust research methodsSujith Ramachandran, Joel Farley, John P Bentley
Journal of Anxiety Disorders|February 23, 2013
National trends of psychotropic medication use among patients diagnosed with anxiety disorders: results from medical expenditure panel survey 2004-2009Chung-Hsuen Wu, Chi-Chuan Wang, Aaron Jacob Katz, et al.
Journal of Psychosocial Oncology|January 18, 2021
The association of continuity of care and risk of mortality in breast cancer patients with cardiometabolic comorbiditiesNing Cheng, Joel Farley, Jingjing Qian, et al.
Exploratory Research in Clinical and Social Pharmacy|August 12, 2022
Implementation of a model integrating primary and oncology pharmacists' care for patients taking oral anticancer agents (OAA)Karen B Farris, Tiffany Cadwallader, Joel Farley, et al.
Journal of Managed Care & Specialty Pharmacy|February 27, 2026
Trends in 1-year persistence and adherence among initiators of high-potency, weight loss-indicated glucagon-like peptide 1 receptor agonistsLandon Z Marshall, Patrick P Gleason, Nicholas Friedlander, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|August 30, 2024
Managing medications for patients with cancer and chronic conditions: It's time for collaboration between primary care and oncology pharmacistsArielle Davidson, Mohamad Ismail, Justin Gatwood, et al.
The Journal of Rheumatology|August 3, 2014
Tumor necrosis factor-α inhibitor treatment and the risk of incident cardiovascular events in patients with early rheumatoid arthritis: a nested case-control studyRishi J Desai, Jaya K Rao, Richard A Hansen, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|April 28, 2023
Impact of initiating oral anticancer agents for leukemia on adherence to medications for multiple chronic conditionsJustin Gatwood, Ankur Dashputre, Abhijeet Rajpurohit, et al.
JCO Oncology Practice|June 14, 2022
Medication Adherence Among Adults With Comorbid Chronic Conditions Initiating Oral Anticancer Agent Therapy for Multiple MyelomaJustin Gatwood, Ankur Dashputre, Abhijeet Rajpurohit, et al.
Pageof 2